Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
American Society of Clinical Oncology
Access Rights
info:eu-repo/semantics/closedAccess
DOI
10.1200/jco.2016.34.4_suppl.615
Abstract
Description
Keywords
Journal or Series
Gastrointestinal Cancers Symposium
WoS Q Value
Scopus Q Value
Volume
34
Issue
4
Citation
Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
